| Factor Information | |
|---|---|
| Data ID | 797 |
| Factor | beta-blocker |
| Description | N/A |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | adolescent and adults with CHD |
| p Value | <0.001 |
| Conclusion | The percent of beta-blocker in non-survivors were significantly higher than that in all patients. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 138 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 28687271 |
| Year | 2018 |
| Title | Number of Thoracotomies Predicts Impairment in Lung Function and Exercise Capacity in Patients With Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | adolescent and adult | |
| Source | data | |
| Region | Germany, Munchen | |
| Method | T-test; bivariate analysis and multivariable analysis | |
| Race | European | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | non-survivors(Treatment) | all patients(Control) |
| Number | 21 | 1372 |
| Age | 42.2±13.7 years(non-survivors) | 32.4±11.5(all patients) |
| Gender (Male: Female) | male:female=12:9 | male:female=757:615 |
| Marker Level | 0.476 | 0.127 |
